U.S. Capital Wealth Advisors’s Amicus Therapeutics FOLD Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$143K	Buy
2023 Q1	–	Sell
2022 Q4	$14.7K	Buy